13F HOLDINGS REPORT
Integral Health Asset Management, LLC
Quarter ended Q2 2023 · Filed May 9, 2023 · Accession 0001420506-23-000901
Total Value
$496.4M
Positions
71
Other Managers
0
Confidential Omitted
No
Holdings (71)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ELEVANCE HEALTH INC | ELV | 51,000 | $23.5M | 4.72% |
| 2 | CYTOKINETICS INC | CYTK | 600,000 | $21.1M | 4.25% |
| 3 | INSPIRE MED SYS INC | 457730109 | 80,000 | $18.7M | 3.77% |
| 4 | COOPER COS INC | 216648402 | 40,000 | $14.9M | 3.01% |
| 5 | STRYKER CORPORATION | SYK | 50,000 | $14.3M | 2.88% |
| 6 | ABBVIE INC | ABBV | 81,000 | $12.9M | 2.60% |
| 7 | RELAY THERAPEUTICS INC | RLAY | 770,000 | $12.7M | 2.55% |
| 8 | VIKING THERAPEUTICS INC | VKTX | 727,100 | $12.1M | 2.44% |
| 9 | HCA HEALTHCARE INC | HCA | 45,000 | $11.9M | 2.39% |
| 10 | TELEFLEX INCORPORATED | TFX | 46,000 | $11.7M | 2.35% |
| 11 | CARDINAL HEALTH INC | CAH | 152,000 | $11.5M | 2.31% |
| 12 | PERKINELMER INC | RVTY | 85,000 | $11.3M | 2.28% |
| 13 | BIOGEN INC | BIIB | 40,000 | $11.1M | 2.24% |
| 14 | EXACT SCIENCES CORP | 30063P105 | 162,000 | $11.0M | 2.21% |
| 15 | SAREPTA THERAPEUTICS INC | SRPT | 75,000 | $10.3M | 2.08% |
| 16 | ZENTALIS PHARMACEUTICALS INC | ZNTL | 600,000 | $10.3M | 2.08% |
| 17 | SAGE THERAPEUTICS INC | 78667J108 | 245,000 | $10.3M | 2.07% |
| 18 | UNIQURE NV | QURE | 500,000 | $10.1M | 2.03% |
| 19 | IDEXX LABS INC | 45168D104 | 20,000 | $10.0M | 2.01% |
| 20 | PENUMBRA INC | PEN | 35,000 | $9.8M | 1.96% |
| 21 | BIOMARIN PHARMACEUTICAL INC | BMRN | 100,000 | $9.7M | 1.96% |
| 22 | VENTYX BIOSCIENCES INC | 92332V107 | 290,000 | $9.7M | 1.96% |
| 23 | HUMANA INC | HUM | 20,000 | $9.7M | 1.96% |
| 24 | MERCK & CO INC | MRK | 90,000 | $9.6M | 1.93% |
| 25 | PTC THERAPEUTICS INC | PTCT | 178,000 | $8.6M | 1.74% |
| 26 | GUARDANT HEALTH INC | GH | 350,000 | $8.2M | 1.65% |
| 27 | BAXTER INTL INC | 071813109 | 200,000 | $8.1M | 1.63% |
| 28 | REVANCE THERAPEUTICS INC | 761330109 | 250,000 | $8.1M | 1.62% |
| 29 | BOSTON SCIENTIFIC CORP | BSX | 152,000 | $7.6M | 1.53% |
| 30 | REVOLUTION MEDICINES INC | RVMDW | 345,000 | $7.5M | 1.51% |
| 31 | ALIGN TECHNOLOGY INC | ALGN | 22,000 | $7.4M | 1.48% |
| 32 | REPLIMUNE GROUP INC | REPL | 395,000 | $7.0M | 1.41% |
| 33 | KRYSTAL BIOTECH INC | KRYS | 85,000 | $6.8M | 1.37% |
| 34 | REATA PHARMACEUTICALS INC | 75615P103 | 71,000 | $6.5M | 1.30% |
| 35 | ENVISTA HOLDINGS CORPORATION | NVST | 152,000 | $6.2M | 1.25% |
| 36 | INARI MED INC | 45332Y109 | 100,000 | $6.2M | 1.24% |
| 37 | HOLOGIC INC | HOLX | 75,000 | $6.1M | 1.22% |
| 38 | MODERNA INC | MRNA | 35,000 | $5.4M | 1.08% |
| 39 | LIFESTANCE HEALTH GROUP INC | LFST | 709,000 | $5.3M | 1.06% |
| 40 | ALKERMES PLC | ALKS | 179,000 | $5.0M | 1.02% |
| 41 | AGIOS PHARMACEUTICALS INC | AGIO | 213,000 | $4.9M | 0.99% |
| 42 | LABORATORY CORP AMER HLDGS | 50540R409 | 20,000 | $4.6M | 0.92% |
| 43 | SUPERNUS PHARMACEUTICALS INC | SUPN | 125,000 | $4.5M | 0.91% |
| 44 | CRISPR THERAPEUTICS AG | CRSP | 100,000 | $4.5M | 0.91% |
| 45 | ARGENX SE | ARGX | 12,000 | $4.5M | 0.90% |
| 46 | ACADIA HEALTHCARE COMPANY IN | ACHC | 61,000 | $4.4M | 0.89% |
| 47 | SURGERY PARTNERS INC | SGRY | 122,000 | $4.2M | 0.85% |
| 48 | NATERA INC | NTRA | 75,000 | $4.2M | 0.84% |
| 49 | ALNYLAM PHARMACEUTICALS INC | ALNY | 20,000 | $4.0M | 0.81% |
| 50 | IRHYTHM TECHNOLOGIES INC | IRTC | 30,000 | $3.7M | 0.75% |
| 51 | CHINOOK THERAPEUTICS INC | 16961L106 | 152,000 | $3.5M | 0.71% |
| 52 | AMICUS THERAPEUTICS INC | FOLD | 305,000 | $3.4M | 0.68% |
| 53 | CATALENT INC | 148806102 | 50,000 | $3.3M | 0.66% |
| 54 | PROMETHEUS BIOSCIENCES INC | 74349U108 | 30,000 | $3.2M | 0.65% |
| 55 | OPTION CARE HEALTH INC | OPCH | 101,000 | $3.2M | 0.65% |
| 56 | AKERO THERAPEUTICS INC | 00973Y108 | 70,000 | $2.7M | 0.54% |
| 57 | REGENERON PHARMACEUTICALS | REGN | 3,000 | $2.5M | 0.50% |
| 58 | ITEOS THERAPEUTICS INC | 46565G104 | 180,000 | $2.4M | 0.49% |
| 59 | LONGBOARD PHARMACEUTICALS IN | 54300N103 | 582,000 | $2.3M | 0.47% |
| 60 | KEROS THERAPEUTICS INC | KROS | 50,000 | $2.1M | 0.43% |
| 61 | ACLARIS THERAPEUTICS INC | ACRS | 250,000 | $2.0M | 0.41% |
| 62 | ALLOGENE THERAPEUTICS INC | ALLO | 405,000 | $2.0M | 0.40% |
| 63 | THE BEAUTY HEALTH COMPANY | 88331L108 | 152,000 | $1.9M | 0.39% |
| 64 | FIBROGEN INC | 31572Q808 | 102,000 | $1.9M | 0.38% |
| 65 | MERUS N V | N5749R900 | 100,000 | $1.8M | 0.37% |
| 66 | ACLARIS THERAPEUTICS INC | ACRS | 225,000 | $1.8M | 0.37% |
| 67 | GOODRX HLDGS INC | GDRX | 203,000 | $1.3M | 0.26% |
| 68 | TERNS PHARMACEUTICALS INC | TERN | 100,000 | $1.2M | 0.24% |
| 69 | NUVALENT INC | NUVL | 35,000 | $913,150 | 0.18% |
| 70 | EXSCIENTIA PLC | 30223G102 | 152,000 | $805,600 | 0.16% |
| 71 | DYNE THERAPEUTICS INC | DYN | 57,000 | $656,640 | 0.13% |